Recruiting
Phase 2

A Study of Barzolvolimab in Patients With Prurigo Nodularis

Sponsor:

Celldex Therapeutics

Code:

NCT06366750

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

barzolvolimab

Matching Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Celldex Therapeutics on 2025-03-25.